Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKeywords Studios Plc Regulatory News (KWS)

Share Price Information for Keywords Studios Plc (KWS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,232.00
Bid: 2,236.00
Ask: 2,238.00
Change: 2.00 (0.09%)
Spread: 2.00 (0.089%)
Open: 2,250.00
High: 2,250.00
Low: 2,230.00
Prev. Close: 2,230.00
KWS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Revolving Credit Facility

5 Jun 2018 07:00

RNS Number : 2610Q
Keywords Studios PLC
05 June 2018
 

05 June 2018

 

Keywords Studios plc ("Keywords", "the Group")

 

New Revolving Credit Facility for up to €105m agreed

 

 

Keywords Studios, the international technical services provider to the global video games industry, today confirms the completion of a new revolving credit facility, in line with the terms outlined in the Group's full year results announcement on 9 April 2018.

 

The new facility is being provided by Barclays Bank plc, HSBC Bank plc and Lloyds Banking Group plc for an initial €75m over a three-year term, with the option to extend the facility up to €105m and by a further two years. It replaces the existing €35m facility and is on improved terms.

 

Andrew Day, Chief Executive of Keywords Studios, commented:

 

"We are pleased to have finalised this significantly expanded facility, on terms which improve upon our previous arrangement, in line with our intention of maintaining a conservative mix of equity and debt funding to support our investments in both the underlying business and new activities.

 

"We have made 4 acquisitions to date this year and, over the last twelve months, we have invested to substantially expand our capacity across six existing and five new facilities.

 

"We are reviewing a strong pipeline of acquisition candidates and organic investment opportunities as we continue to build our business organically and through acquisition. This facility gives us the flexibility and headroom to act on our investment decisions whilst continuing to enhance shareholder value."

 

 

 

For further information, please contact:

Keywords Studios (www.keywordsstudios.com)

Andrew Day, Chief Executive Officer

David Broderick, Chief Financial Officer

+353 190 22 730

 

Numis (Financial Adviser)

Stuart Skinner / Kevin Cruickshank (Nominated Adviser)

James Black / Tom Ballard (Corporate Broker)

 

020 7260 1000

 

MHP Communications (Financial PR)

Katie Hunt / Ollie Hoare

 

 

020 3128 8100

keywords@mhpc.com

 

About Keywords Studios (www.keywordsstudios.com)

 

Keywords Studios is an international technical services provider to the global video games industry. Established in 1998, and now with over 40 facilities in 20 countries strategically located in Asia, the Americas and Europe, it provides integrated art creation, software engineering, testing, localisation, audio and customer care services across more than 50 languages and 16 games platforms to a blue-chip client base of approximately 650 clients across the globe. It has a strong market position, providing services to 23 of the top 25 most prominent games companies, including Activision Blizzard, Bandai Namco, Bethesda, Electronic Arts, Konami, Riot Games, Sony, Square Enix, Supercell, TakeTwo, and Ubisoft. Recent titles worked on include Uncharted 4: A Thief's End, Call of Duty: WWII, Mortal Combat X, Assassin's Creed Origins, Battlefield 1, League of Legends, Fortnite, Clash Royale, and Mobile Strike. Keywords Studios is listed on AIM, the London Stock Exchange regulated market (KWS.L).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAXKLEFDPEFF
Date   Source Headline
11th Aug 202312:42 pmRNSDirector/PDMR Shareholding
4th Aug 20239:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:12 pmRNSDirector Share Purchase
1st Aug 20239:57 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSH1 Trading Update
28th Jul 20237:37 amRNSIssue of Shares
25th Jul 202310:42 amRNSHolding(s) in Company
21st Jul 20237:00 amRNSNew Revolving Credit Facility of $400 million
3rd Jul 202311:26 amRNSTotal Voting Rights
3rd Jul 202310:25 amRNSHolding(s) in Company
21st Jun 20237:00 amRNSAppointment of Chief Financial Officer
19th Jun 20232:59 pmRNSHolding(s) in Company
14th Jun 20237:00 amRNSExtension of EBT Market Purchases to EUR15 million
12th Jun 20237:16 amRNSIssue of Shares
9th Jun 20237:00 amRNSDirector Share Purchase
8th Jun 20232:42 pmRNSHolding(s) in Company
1st Jun 20233:53 pmRNSTotal Voting Rights
26th May 20232:55 pmRNSResult of AGM
24th May 20234:06 pmRNSDirector/PDMR Shareholding
23rd May 20233:34 pmRNSIssue of Shares
23rd May 20231:45 pmRNSHolding(s) in Company
22nd May 20234:10 pmRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSBlock listing return
15th May 20237:00 amRNSPassing of Ross Graham and Chairman Succession
11th May 20234:45 pmRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSAcquisition
9th May 20237:00 amRNSDirector/PDMR Shareholding
2nd May 20234:49 pmRNSTotal Voting Rights
18th Apr 20239:46 amRNSBlock Admission
17th Apr 20237:00 amRNSPublication of Annual Report and Accounts
3rd Apr 20239:59 amRNSTotal Voting Rights
3rd Apr 20238:56 amRNSIssue of Shares
31st Mar 202312:11 pmRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSAcquisition
15th Mar 20237:00 amRNSFinal Results
9th Mar 20233:32 pmRNSIssue of Shares
1st Mar 20234:56 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSTotal Voting Rights
13th Feb 20231:38 pmRNSIssue of Shares
1st Feb 20237:01 amRNSTotal Voting Rights
1st Feb 20237:00 amRNSAcquisition
25th Jan 20237:00 amRNSFull Year Trading Update
19th Jan 20237:00 amRNSDirectorate Change
16th Jan 20232:16 pmRNSHolding(s) in Company
12th Jan 202312:17 pmRNSIssue of Shares
3rd Jan 20237:00 amRNSTotal Voting Rights
16th Dec 20229:00 amRNSAcquisition
13th Dec 20227:00 amRNSAcquisition
9th Dec 20225:02 pmRNSDirector/PDMR Shareholding
8th Dec 20224:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.